Visiongain Report Offers Transformative Insights on $47bn Rheumatoid Arthritis Market

Visiongain Report Offers Transformative Insights on $47bn Rheumatoid Arthritis Market

PR Newswire

LONDON, January 11, 2019

LONDON, January 11, 2019 /PRNewswire/ --

Global Rheumatoid Arthritis Drugs Market Forecast 2019-2029 

Biologics, Non-Biologics, NSAIDs, sDMARDs and Others 

The global rheumatoid arthritis drugs market will reach $47bn in 2024. In 2018, the Biologics submarket held 87% of the Global Rheumatoid Arthritis Drugs market.

     (Logo: https://mma.prnewswire.com/media/523989/Visiongain_Logo.jpg )

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 232-page report you will receive 234 charts- all unavailable elsewhere.

The 232-page report provides clear detailed insight into the rheumatoid arthritis market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope 

Global Rheumatoid Arthritis Market from 2019-2029 

• Forecast of the Global Rheumatoid Arthritis market by Submarket:
• Biologics
• Non-Biologics: NSAIDs, sDMARDs and Others

• Forecast of the leading drugs in the Global Rheumatoid Arthritis market:
• Humira
• Enbrel
• Remicade
• Rituxan/MabThera
• Simponi/Simponi Aria
• Orencia
• Actemra/Roactemra
• Cimzia
• Celebrex
• Xeljanz
• Arcoxia
• Others

• This report provides individual revenue forecasts to 2029 for these regional and national markets:
North America: US, Canada
Europe: Germany, France, United Kingdom, Italy, Spain, Russia and rest of Europe
Asia-Pacific: Japan, China, India and rest of Asia-Pacific
Latin America: Brazil, Mexico, Rest of Latin America
Middle East & Africa: Saudi Arabia, South Africa, Rest of MEA

Each regional market is further segmented into Biologics, Non-Biologics, NSAIDs, sDMARDs and Others

• Our study discusses the selected leading companies that are the major players in the rheumatoid arthritis market:
• AbbVie
• Amgen
• AstraZeneca
• BMS
• Eli Lilly
• Johnson & Johnson
• Merck & Co
• Novartis
• Pfizer
• Roche
• Sanofi
• UCB

• Our study discusses selected compounds under development for rheumatoid arthritis.

• This study provides a SWOT and STEP analysis of the rheumatoid arthritis drugs market.

Visiongain's study is intended for anyone requiring commercial analyses for the rheumatoid arthritis market. You find data, trends and predictions.

Buy our report today Global Rheumatoid Arthritis Drugs Market Forecast 2019-2029: Biologics, Non-Biologics, NSAIDs, sDMARDs and Others

To request a report overview of this report please contact Sara Peerun at sara.peerun@visiongain.com or refer to our website: https://www.visiongain.com/report/global-rheumatoid-arthritis-drugs-market-forecast-2019-2029/

Did you know that we also offer a report add-on service? Email sara.peerun@visiongain.com to discuss any customized research needs you may have.

Abbvie
Ablynx
Abott Laboratories
Alder
Amgen
Astellas Pharma Inc.
Baxalta
Biocad
Biocon Limited
Biogen Inc.
Bioxpress Therapeutics
BMS
Boehringer Ingelheim
Bristol-Myers Squibb Company
Cadila Healthcare
Can-Fite
Celtrion
Chugai Pharmaceutical Co Ltd.
Cipla
Coherus BioSciences Inc
Covagen AG
Daiichi Sankyo
Dermira, Inc.
Dr Reddy's Laboratories
Eli Lilly
Epirus Biopharmaceuticals
F. Hoffmann-La Roche Ltd (Roche)
Fujifilm Corporation
Fujifilm Kyowa Kirin
Galapagos NV
Genentech
Gerresheimer
Gilead Sciences Inc
GlaxoSmithKline plc
Hanmi Pharmaceutical
Hanwha Chemical
Hetero Group
Hospira
IMS Health
Incyte Corporation
Intas Pharmaceuticals Limited
Janseen Biologics
Johnson and Johnson
LG Life Sciences
Lycera Corporation
Merck KGaA
Mitsubishi
Momenta Pharmaceuticals
MorphoSys
Mycenax Biotech Inc.
Mylan N.V.
Nichi-Iko Pharmaceutical
Novartis
Novo Nordisk
Oncobiologics
Padlock
Pfenex
Pfizer
Protalix Biotherapeutics
Regeneron Pharmaceuticals, Inc.
Roche
Samsung Bioepis
Sanofi S.A.
Shanghai Celgen
Shanghai CP Goujian Pharmaceutical Co
Sharp & Dhome
Simcere Pharmaceuticals
Sun Pharma
Takeda Pharmaceuticals
Tanabe Pharma
Torrent Pharmaceuticals
TSH Biopharm
UCB
Van der Heijde
Vitaeris
Zydus Cadila

Other Organizations Mentioned in This Report
African League of Associations in Rheumatology
American College of Rheumatology
ANVISA (Agência Nacional de Vigilância Sanitária)
Arthritis Foundation
Bumrungrad
Canadian Arthritis Society
Centers for Disease Control and Prevention (CDC)
Cleveland Clinic
Committee for Medicinal Products for Human Use (CHMP)
Emirates Arthritis Foundation
European Commission
European Medicines Agency
Government of Abu Dhabi
Institut fϋr Qualität und Wirtschaftlichkeit im Gesundheitswesen - IQWiG
Institute for Quality and Efficiency in Healthcare
International League of Associations for Rheumatology
Johns Hopkins
Ministry of Health
National Center for Biotechnology Information
National Institute for Health and Care Excellence (NICE)
National Institute for Health Research (NIHR)
National Institute on Aging
National Rheumatoid Arthritis Society
National Treasury of Republic of South Africa
Nurses Health
Servizio Sanitario Nazionale (SSN)
U.S. Food and Drug Administration (FDA)
Unified Health System
United Nations
US Patent Office
Vamed
WHO
World Arthritis Day
World Bank

To see a report overview please e-mail Sara Peerun on sara.peerun@visiongain.com

Voltar noticias em Inglês